Gadiyaram Muralikrishna parted with a total of 170 thousand shares of Helios and Matheson Analytics Inc. (HMNY) at average share price of $13. This insider trade in the company took place on 11/17/2017. The total for the sales was set at $2.21 million. After this transaction, the Director, 10% Owner account balance stood at 2.32 million shares. The stock lost -99.85 percent since that insider sale.
On momentum oscillators front, ‘RSI’ has touched 51.46 on daily chart, which may remain a cause for concern. If the price breaks below $0.02 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $0.02 mark may result into a pull-back move towards $0.02 level. The stock is currently hovering around the first support level of $0.02. Below this, the next support is placed in the zone of $0.02. Till the time, the HMNY stock trades above this level, bulls have nothing to fear.
Shares of Helios and Matheson Analytics Inc. (HMNY) are trading at a P/E ratio of 0 times earnings reported for the past 12 months. The industry HMNY operates in has an average P/E of 22.12. Its P/E ratio went as low as 34.99X and as high as 34.99 over the 5-year span. Further, it is sporting a 0.14 on the Price-to-Sales ratio. Compare this with the industry average P/S of 534.69. 0 percent is the gross profit margin for Helios and Matheson Analytics Inc. and operating margin sits at 0 percent. Along with this, the net profit margin is 0 percent.
On 31st of December, Helios and Matheson Analytics Inc. (NASDAQ:HMNY) shares ended higher after a volatile session. The shares accumulated 0 points or 1.27 percent at $0.02 with a light trade volume of 36.629 million shares. After opening the session at $0.0163, the shares went as high as $0.018 and as low as $0.0158, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $30.17 million and now has 1.89 billion shares outstanding. Helios and Matheson Analytics Inc. (HMNY) stock has lost -5.88 percent of market value in 21 trading days.
HMNY stock has a trailing 3-year beta of 0.98, offering the possibility of a lower rate of return, but also posing less risk. The portion of a company’s profit allocated to each outstanding share of common stock was -$1.71 a share in the trailing twelve months. The stock’s value has fallen -100 percent year to date (YTD) against a decline of -100 percent in 12 month’s time. The company’s shares still trade -100 percent away from its 1-year high of $2662.50 and 45.45 percent up from 52-week low of $0.01. The average consensus rating on the company is 3, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a hold.